Repository logo
 

Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.

Simple item page
dc.contributor.authorLandovitz, Raphael J.
dc.contributor.authorLi, Sue.
dc.contributor.authorGrinsztejn, Beatriz.
dc.contributor.authorDawood, Halima.
dc.contributor.authorLiu, Albert Y.
dc.contributor.authorMagnus, Manya.
dc.contributor.authorHosseinipour, Mina C.
dc.contributor.authorPanchia, Ravindre.
dc.contributor.authorCottle, Leslie.
dc.contributor.authorChau, Gordon.
dc.contributor.authorRichardson, Paul.
dc.contributor.authorMarzinke, Mark Albert.
dc.contributor.authorHendrix, Craig W.
dc.contributor.authorEshleman, Susan H.
dc.contributor.authorZhang, Yinfeng.
dc.contributor.authorTolley, Elizabeth E.
dc.contributor.authorSugarman, Jeremy.
dc.contributor.authorKofron, Ryan.
dc.contributor.authorAdeyeye, Adeola.
dc.contributor.authorBurns, David.
dc.contributor.authorRinehart, Alex R.
dc.contributor.authorMargolis, David.
dc.contributor.authorSpreen, William R.
dc.contributor.authorCohen, Myron S.
dc.contributor.authorMcCauley, Marybeth.
dc.contributor.authorEron, Joseph J.
dc.date.accessioned2019-12-15T15:43:36Z
dc.date.available2019-12-15T15:43:36Z
dc.date.created2018
dc.date.issued2018
dc.descriptionCAPRISA, 2018.en_US
dc.description.abstractAbstract available in pdf.en_US
dc.identifier.citationLandovitz, R.J., Li, S., Grinsztejn, B., Dawood, H., Liu, A.Y., Magnus, M., Hosseinipour, M.C., Panchia, R., Cottle, L., Chau, G., Richardson, P., Marzinke, M., Hendrix, C.W., Eshleman, S.H., Zhang, Y., Tolley, E., Sugarman, J., Kofron, R., Adeyeye, A., Burns, D., Rinehart, A.R., Margolis, D., Spreen, W.R., Cohen, M.S., McCauley, M.and Eron, J.J. 2018. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Medicine 15(11), e1002690.en_US
dc.identifier.urihttp://dx.doi.org/10.1371/journal.pmed.1002690en_US
dc.identifier.urihttps://researchspace.ukzn.ac.za/handle/10413/16641
dc.language.isoenen_US
dc.publisherPublic Library of Science.en_US
dc.subjectAdolescent.en_US
dc.subjectAdult.en_US
dc.subjectAnti-HIV Agents/adverse effects.en_US
dc.subjectAnti-HIV Agents/blood.en_US
dc.subjectAnti-HIV Agents/pharmacokinetics.en_US
dc.titleSafety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.en_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Landovitz Raphael J_2018.pdf
Size:
2.87 MB
Format:
Adobe Portable Document Format
Description:
Main article.
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.64 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research papers (Caprisa)